Workflow
康为世纪: 中信证券股份有限公司关于江苏康为世纪生物科技股份有限公司预计2025年度日常关联交易的专项核查意见
证券之星·2025-08-30 01:25

| | | | | | | | | | | | | 单位:万元 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 占同 | | | | | 本年年初 | | | | | 占 | 同 | | | | 类业 | | | | 至 | 6 月 | 30 | | | 类 | | 业 | | | | | | | | | | | 上年实 | | | | | | | | 关联交易类 | | 本次预 | | 务比 | | 日与关联 | | | | | | 务 比 | 本次预 | | 计金额与上年实际发生 | | | | | | | | | | | | | | | 关联人 | | | | | | | 际发生 | | | | | | | | 别 | 计金额 | | 例 | | | 人累计已 | | | | | 例 | | 金额差异较 | | 大的原因 | | | | | | | | | | | | | | | | | | | | | | 金额 | | | | | | | | (% | | | | | ...